Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.
2.

Fingolimod: a review of its use in the management of relapsing-remitting multiple sclerosis.

Scott LJ.

CNS Drugs. 2011 Aug;25(8):673-98. doi: 10.2165/11207350-000000000-00000. Review.

PMID:
21790210
[PubMed - indexed for MEDLINE]
3.

Oral fingolimod for the treatment of patients with relapsing forms of multiple sclerosis.

Singer B, Ross AP, Tobias K.

Int J Clin Pract. 2011 Aug;65(8):887-95. doi: 10.1111/j.1742-1241.2011.02721.x. Epub 2011 Jun 16. Review.

PMID:
21679286
[PubMed - indexed for MEDLINE]
4.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
[PubMed - indexed for MEDLINE]
5.

Fingolimod-associated macular edema: incidence, detection, and management.

Jain N, Bhatti MT.

Neurology. 2012 Feb 28;78(9):672-80. doi: 10.1212/WNL.0b013e318248deea. Review.

PMID:
22371414
[PubMed - indexed for MEDLINE]
6.

[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].

Széplaki G, Merkely B.

Ideggyogy Sz. 2012 Nov 30;65(11-12):369-76. Review. Hungarian.

PMID:
23289171
[PubMed - indexed for MEDLINE]
7.

Fingolimod for relapsing multiple sclerosis: an update.

Horga A, Castilló J, Montalban X.

Expert Opin Pharmacother. 2010 May;11(7):1183-96. doi: 10.1517/14656561003769866. Review.

PMID:
20367536
[PubMed - indexed for MEDLINE]
8.

Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.

Sanford M, Lyseng-Williamson KA.

Drugs. 2011 Oct 1;71(14):1865-91. doi: 10.2165/11207540-000000000-00000. Review.

PMID:
21942977
[PubMed - indexed for MEDLINE]
9.

Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.

McCormack PL, Scott LJ.

CNS Drugs. 2004;18(8):521-46. Review.

PMID:
15182221
[PubMed - indexed for MEDLINE]
10.

Interferon-β-1b: a review of its use in multiple sclerosis.

Plosker GL.

CNS Drugs. 2011 Jan;25(1):67-88. doi: 10.2165/11206430-000000000-00000. Review.

PMID:
21128695
[PubMed - indexed for MEDLINE]
11.

Spotlight on Interferon-beta-1b in relapsing-remitting and secondary progressive multiple sclerosis.

McCormack PL, Scott LJ.

BioDrugs. 2004;18(5):343-7. Review.

PMID:
15377176
[PubMed - indexed for MEDLINE]
12.

Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis.

Yeh EA, Weinstock-Guttman B.

Adv Ther. 2011 Apr;28(4):270-8. doi: 10.1007/s12325-011-0004-6. Epub 2011 Mar 7. Review.

PMID:
21394595
[PubMed - indexed for MEDLINE]
13.

First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview.

Johnston J, So TY.

Drugs. 2012 Jun 18;72(9):1195-211. doi: 10.2165/11634010-000000000-00000. Review.

PMID:
22642799
[PubMed - indexed for MEDLINE]
14.

Clinical pharmacokinetics of fingolimod.

David OJ, Kovarik JM, Schmouder RL.

Clin Pharmacokinet. 2012 Jan 1;51(1):15-28. doi: 10.2165/11596550-000000000-00000. Review.

PMID:
22149256
[PubMed - indexed for MEDLINE]
15.

Fingolimod: a novel immunosuppressant for multiple sclerosis.

Brown BA, Kantesaria PP, McDevitt LM.

Ann Pharmacother. 2007 Oct;41(10):1660-8. Epub 2007 Sep 4. Review.

PMID:
17785617
[PubMed - indexed for MEDLINE]
16.

Complementary and alternative therapies for back pain II.

Furlan AD, Yazdi F, Tsertsvadze A, Gross A, Van Tulder M, Santaguida L, Cherkin D, Gagnier J, Ammendolia C, Ansari MT, Ostermann T, Dryden T, Doucette S, Skidmore B, Daniel R, Tsouros S, Weeks L, Galipeau J.

Evid Rep Technol Assess (Full Rep). 2010 Oct;(194):1-764. Review.

PMID:
23126534
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk